AMPD1 and differentiated thyroid carcinoma: Luo et al. (2018) identified that AMPD1 was closely associated with the survival of breast cancer patients. Zha & Wu (2018) found that the expression of AMPD1 in serum of patients with papillary thyroid carcinoma is closely related to the malignant evolution of PTC and clinical prognosis of patients.